[Federal Register Volume 67, Number 153 (Thursday, August 8, 2002)]
[Notices]
[Page 51584]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-20037]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol 
Effect: Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following Federal advisory committee 
meeting.

    Name: National Task Force on Fetal Alcohol Syndrome and Fetal 
Alcohol Effect (NTFFASFAE).
    Times and Dates:
    8:30 a.m.-4:30 p.m., September 20, 2002.
    8:30 a.m.-12 noon, September 21, 2002.
    Place: Hyatt Regency, 265 Peachtree Street, N.E., Atlanta, 
Georgia 30303, telephone 404/577-1234, fax 404/588-3752.
    Status: Open to the public, limited only by the space available. 
The meeting room accommodates approximately 65 people.
    Purpose: The Secretary is authorized by the Public Health 
Service Act, section 399H, (42 U.S.C. 280f, as added by Public Law 
105-392) to establish a National Task Force on Fetal Alcohol 
Syndrome and Fetal Alcohol Effect to: (1) Foster coordination among 
all governmental agencies, academic bodies and community groups that 
conduct or support Fetal Alcohol Syndrome (FAS) and Fetal Alcohol 
Effect (FAE) research, programs and surveillance; and (2) to 
otherwise meet the general needs of populations actually or 
potentially impacted by FAS and FAE.
    Matters To Be Discussed: Discussions will focus on ways the Task 
Force can collaborate with CDC and other Federal agencies on issues 
of diagnostic criteria for FAS/Alcohol Related Neurodevelopmental 
Disorder (ARND) in order to enhance health care providers' 
recognition of these disorders, and to ensure that those affected 
and their families receive needed services; the special needs of 
birth mothers of children with FAS/ARND; a report of the Substance 
Abuse and Mental Health Services Administration FAS/FAE Center for 
Excellence on their initial ``stakeholders'' meetings and future 
plans; an update on activities from the Interagency Coordinating 
Committee on Fetal Alcohol Syndrome; new research and program 
updates from the CDC; and a discussion of the implementation of the 
Task Force recommendations by various governmental agencies. 
Additional agenda items include: Working group updates; discussion 
of future topics, and scheduling the next meeting.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: R. Louise Floyd, DSN, RN, 
Designated Federal Official, National Center on Birth Defects and 
Developmental Disabilities, CDC, 4700 Buford Highway, NE, (F-49), 
Atlanta, Georgia 30333, telephone 770/488-7372, fax 770/488-7361.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities for both the CDC and ATSDR.

    Dated: August 2, 2002.
John Burckhardt,
Acting Director, Management Analysis and Services Office, , Centers for 
Disease Control and Prevention.
[FR Doc. 02-20037 Filed 8-7-02; 8:45 am]
BILLING CODE 4163-18-P